C66H86N8O9
Neat
1135.46
VZ8PUA68U3; Lopinavir impurity D; Lopinavir impurity D [WHO-IP]; UNII-VZ8PUA68U3; 1989516-33-7; Lopinavir carboxymethyl dimer; (2S)-N-[(1S, 3S, 4S)-1-benzyl-4-({[4-(2-{[(1S, 2S, 4S)-1-benzyl-2-hydroxy-4-{[(2S)-3-methyl-2-(2-oxotetrahydropyrimidin-1(2H)-yl)butanoyl]amino}-5-phenylpentyl]amino}-2-oxoethyl)-2, 6-dimethylphenoxy]acetyl}amino)-3-hydroxy-5-phenylpentyl]-3-methyl-2-(2-oxotetrahydropyrimidin-1(2H)-yl)butanamide; 1(2H)-Pyrimidineacetamide, tetrahydro-N-[(1S, 3S, 4S)-3-hydroxy-4-[[2-[4-[2-[[(1S, 2S, 4S)-2-hydroxy-4-[[(2S)-3-methyl-1-oxo-2-(tetrahydro-2-oxo-1(2H)-pyrimidinyl)butyl]amino]-5-phenyl-1-(phenylmethyl)pentyl]amino]-2-oxoethoxy]-3, 5-dimethylphenyl]acetyl]amino]-5-phenyl-1-(phenylmethyl)pentyl]-alpha-(1-methylethyl)-2-oxo- and (alphaS)-
(2S)-N-[(2S, 4S, 5S)-4-hydroxy-5-[[2-[4-[2-[[(2S, 3S, 5S)-3-hydroxy-5-[[(2S)-3-methyl-2-(2-oxo-1, 3-diazinan-1-yl)butanoyl]amino]-1, 6-diphenylhexan-2-yl]amino]-2-oxoethoxy]-3, 5-dimethylphenyl]acetyl]amino]-1, 6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1 and 3-diazinan-1-yl)butanamide
InChI=1S/C66H86N8O9/c1-43(2)60(73-31-19-29-67-65(73)81)63(79)69-52(35-47-21-11-7-12-22-47)40-56(75)54(37-49-25-15-9-16-26-49)71-58(77)39-51-33-45(5)62(46(6)34-51)83-42-59(78)72-55(38-50-27-17-10-18-28-50)57(76)41-53(36-48-23-13-8-14-24-48)70-64(80)61(44(3)4)74-32-20-30-68-66(74)82/h7-18,21-28,33-34,43-44,52-57,60-61,75-76H,19-20,29-32,35-42H2,1-6H3,(H,67,81)(H,68,82)(H,69,79)(H,70,80)(H,71,77)(H,72,78)/t52-,53-,54-,55-,56-,57-,60-,61-/m0/s1